Welcome to the Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre contains useful information for healthcare professionals on the epidemiology, etiology, diagnosis and treatment options for male hypogonadism resulting in reduced levels of circulating testosterone.

As well as the disease and treatment information contained within the Knowledge Centre, the Publications Digest presents an analysis of recent literature each month, with insights and commentary on the relevance to clinical practice.

Treatment with testosterone improves cardiovascular risk factors in obese hypogonadal men, with or without type 2 diabetes mellitus

Obesity is a well-known risk factor for the development of cardiovascular disorders. Globally, obese patients have a higher risk of morbidity1,2 and mortality;3 risk of type 2 diabetes, cardiovascular mortality, and premature death is increased by ~30% in obese patients.4 In addition, obesity leads to a decrease in serum testosterone and vice versa. This summary discusses...

View Featured Summary

Latest Publication Summaries

Knowledge Centre

The Hypogonadism Knowledge Centre presents comprehensive, fully referenced educational content to assist healthcare professionals in understanding current best practice approaches to diagnosis and management of male hypogonadism.

Hypogonadism Disease Awareness​​

Learn More